THERAZONE ApS: Financial statements 2013
CVR: 27255574
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -1,127 and a net result of DKK -234,118 compared with DKK 192,648 the year before. Equity in the 2013 report amounted to DKK -103,394.
- Gross Profit
- DKK -1,127
- Profit/Loss
- DKK -234,118
- Equity
- DKK -103,394
- Total Assets
- DKK 711,003
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -1 t. | -234 t. | -103 t. | - |
| 2012 | - | -12 t. | 193 t. | 131 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
THERAZONE ApS has published its annual report for 2012. Gross profit came to DKK -11,722, and the net result was DKK 192,648.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. The company has 2 employees (2026). In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.